Literature DB >> 34865269

Guiding Transition Metal-Doped Hollow Cerium Tandem Nanozymes with Elaborately Regulated Multi-Enzymatic Activities for Intensive Chemodynamic Therapy.

Shuming Dong1, Yushan Dong1, Bin Liu1, Jing Liu1, Shikai Liu1, Zhiyu Zhao2, Wenting Li1, Boshi Tian1, Ruoxi Zhao1, Fei He1, Shili Gai1, Ying Xie3, Piaoping Yang1, Yanli Zhao4.   

Abstract

Clinical applications of nanozyme-initiated chemodynamic therapy (NCDT) have been severely limited by the poor catalytic efficiency of nanozymes, insufficient endogenous hydrogen peroxide (H2 O2 ) content, and its off-target consumption. Herein, the authors developed a hollow mesoporous Mn/Zr-co-doped CeO2 tandem nanozyme (PHMZCO-AT) with regulated multi-enzymatic activities, that is, the enhancement of superoxide dismutase (SOD)-like and peroxidase (POD)-like activities and inhibition of catalase (CAT)-like activity. PHMZCO-AT as a H2 O2 homeostasis disruptor promotes H2 O2 evolution and restrains off-target elimination of H2 O2 to achieve intensive NCDT. PHMZCO-AT with SOD-like activity catalyzes endogenous superoxide anion (O2 •- ) into H2 O2 in the tumor region. The suppression of CAT activity and depletion of glutathione by PHMZCO-AT largely weaken the off-target decomposition of H2 O2 to H2 O. Elevated H2 O2 is then catalyzed by the downstream POD-like activity of PHMZCO-AT to generate toxic hydroxyl radicals, further inducing tumor apoptosis and death. T1 -weighted magnetic resonance imaging and X-ray computed tomography imaging are also achieved using PHMZCO-AT due to the existence of paramagnetic Mn2+ and the high X-ray attenuation ability of elemental Zr, permitting in vivo tracking of the therapeutic process. This work presents a typical paradigm to achieve intensive NCDT efficacy by regulating multi-enzymatic activities of nanozymes to perturb the H2 O2 homeostasis.
© 2022 Wiley-VCH GmbH.

Entities:  

Keywords:  cancer treatment; chemodynamic therapy; hollow cerium; homeostasis disruptor; tandem nanozymes

Mesh:

Substances:

Year:  2022        PMID: 34865269     DOI: 10.1002/adma.202107054

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  6 in total

Review 1.  Manganese-based hollow nanoplatforms for MR imaging-guided cancer therapies.

Authors:  Shuang Liang; Guangfu Liao; Wenzhen Zhu; Li Zhang
Journal:  Biomater Res       Date:  2022-07-06

Review 2.  Insights on catalytic mechanism of CeO2 as multiple nanozymes.

Authors:  Yuanyuan Ma; Zhimin Tian; Wenfang Zhai; Yongquan Qu
Journal:  Nano Res       Date:  2022-07-11       Impact factor: 10.269

Review 3.  Antioxidant Therapy in Cancer: Rationale and Progress.

Authors:  Maochao Luo; Li Zhou; Zhao Huang; Bowen Li; Edouard C Nice; Jia Xu; Canhua Huang
Journal:  Antioxidants (Basel)       Date:  2022-06-08

Review 4.  Nanozymes: Versatile Platforms for Cancer Diagnosis and Therapy.

Authors:  Xiaodong Zhang; Xiaokai Chen; Yanli Zhao
Journal:  Nanomicro Lett       Date:  2022-04-06

5.  Metal-fluorouracil networks with disruption of mitochondrion enhanced ferroptosis for synergistic immune activation.

Authors:  Lingling Lei; Zhe Dong; Li Xu; Fengrui Yang; Baoli Yin; Youjuan Wang; Renye Yue; Guoqiang Guan; Juntao Xu; Guosheng Song; Xiao-Bing Zhang
Journal:  Theranostics       Date:  2022-08-21       Impact factor: 11.600

6.  pH-responsive theranostic nanoplatform of ferrite and ceria co-engineered nanoparticles for anti-inflammatory.

Authors:  Yuanyao Dou; Yimin Zhang; Caiyu Lin; Rui Han; Yubo Wang; Di Wu; Jie Zheng; Conghua Lu; Liling Tang; Yong He
Journal:  Front Bioeng Biotechnol       Date:  2022-09-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.